医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity

摘要Small ubiquitin-related modifier(SUMOylation)is a dynamic post-translational modification that maintains cardiac function and can protect against a hypertrophic response to cardiac pressure overload.However,the function of SUMOylation after myocardial infarction(MI)and the molecular details of heart cell responses to SUMO1 deficiency have not been determined.In this study,we demonstrated that SUMO1 protein was inconsistently abundant in different cell types and heart regions after MI.However,SUMO1 knockout significantly exacerbated systolic dysfunction and infarct size after myocardial injury.Single-nucleus RNA sequencing revealed the differential role of SUMO1 in regulating heart cells.Among cardiomyocytes,SUMO1 deletion increased the Nppa+Nppb+Ankrd1+cardiomyocyte subcluster pro-portion after MI.In addition,the conversion of fibroblasts to myofibroblasts subclusters was inhibited in SUMO1 knockout mice.Importantly,SUMO1 loss promoted proliferation of endothelial cell subsets with the ability to reconstitute neovascularization and expressed angiogenesis-related genes.Computational analysis of ligand/receptor interactions suggested putative pathways that mediate cardiomyocytes to endothelial cell communication in the myocardium.Mice preinjected with cardiomyocyte-specific AAV-SUMO1,but not the endothelial cell-specific form,and exhibited ameliorated cardiac remodeling following MI.Collectively,our results identified the role of SUMO1 in cardiomyocytes,fibroblasts,and endothelial cells after Ml.These findings provide new insights into SUMO1 involvement in the patho-genesis of MI and reveal novel therapeutic targets.

更多
广告
作者 Zhihao Liu [1] Xiaozhi Liu [2] Li Liu [1] Ying Wang [2] Jie Zheng [2] Lan Li [3] Sheng Li [4] Han Zhang [3] Jingyu Ni [3] Chuanrui Ma [5] Xiumei Gao [3] Xiyun Bian [2] Guanwei Fan [6] 学术成果认领
作者单位 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin,300193,China;State Key Laboratory of Component-Based Chinese Medicine,Tianjin,301617,China [1] Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants,The Fifth Central Hospital of Tianjin,Tianjin,300450,China [2] State Key Laboratory of Component-Based Chinese Medicine,Tianjin,301617,China;Haihe Laboratory of Modern Chinese Medicine,Tianjin,301617,China [3] State Key Laboratory of Component-Based Chinese Medicine,Tianjin,301617,China [4] First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin,300193,China [5] First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin,300193,China;State Key Laboratory of Component-Based Chinese Medicine,Tianjin,301617,China;Haihe Laboratory of Modern Chinese Medicine,Tianjin,301617,China [6]
栏目名称
发布时间 2023-04-28(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览8
  • 下载1
药物分析学报(英文版)

药物分析学报(英文版)

2023年13卷2期

170-186页

SCIMEDLINEISTICCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷